(2026). Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer. PLoS Biology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Argonaute 2 Drives Resistance to Immune Checkpoint Inhibitors in Immunorefractory Non-small Cell Lung Cancer."
PLoS Biology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Argonaute 2 Drives Resistance to Immune Checkpoint Inhibitors in Immunorefractory Non-small Cell Lung Cancer."
PLoS Biology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.